16.11.2015 - Mylan’s seven month-long, $26 billion long-shot hostile bid for Perrigo has ended in defeat for the Netherlands-based drugmaker. By the target deadline of Friday, Nov. 13, only 40%...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)